Dr. John M Wallmark
Claim this profileGSK Investigational Site
Studies Tumors
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
3 drugs studied
Area of expertise
1Tumors
Stage IV
Stage III
2Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR positive
Affiliated Hospitals
Clinical Trials John M Wallmark is currently running
TSR-022
for Cancer
This trial is testing TSR-022, a new medicine that helps the immune system fight cancer by blocking a protein called TIM-3. TIM-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that blocking TIM-3 with other treatments enhances the body's ability to fight tumors and suppress their growth. It targets patients with tumors, especially those who may not respond to standard treatments. The goal is to see if this medicine can help the immune system better attack cancer cells.
Recruiting1 award Phase 1
TSR-022
for Advanced Cancer
This trial is testing TSR-022, a new medicine that helps the immune system fight cancer by blocking a protein called TIM-3. TIM-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that blocking TIM-3 with other treatments enhances the body's ability to fight tumors and suppress their growth. It targets patients with tumors, especially those who may not respond to standard treatments. The goal is to see if this medicine can help the immune system better attack cancer cells.
Recruiting1 award Phase 1
More about John M Wallmark
Clinical Trial Related8 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments John M Wallmark has experience with
- TSR-022
- Quaratusugene Ozeplasmid
- Osimertinib
Breakdown of trials John M Wallmark has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John M Wallmark specialize in?
John M Wallmark focuses on Tumors and Non-Small Cell Lung Cancer. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is John M Wallmark currently recruiting for clinical trials?
Yes, John M Wallmark is currently recruiting for 3 clinical trials in Rockville Maryland. If you're interested in participating, you should apply.
Are there any treatments that John M Wallmark has studied deeply?
Yes, John M Wallmark has studied treatments such as TSR-022, Quaratusugene Ozeplasmid, Osimertinib.
What is the best way to schedule an appointment with John M Wallmark?
Apply for one of the trials that John M Wallmark is conducting.
What is the office address of John M Wallmark?
The office of John M Wallmark is located at: GSK Investigational Site, Rockville, Maryland 20850 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.